As Generics Wave Builds, Novo Nordisk Cuts Ozympic, Vigoy Prices

Business Standard

In a bid to compete with cheaper generics, Danish drugmaker Novo Nordisk on Monday announced a 36 percent and 48 percent price cut for its injectable semaglutide brands Ozympic and Vigovi in ​​India, respectively. However, senior executives told Business Standard that the company is not planning a similar move for its oral semaglutide brand, Rebelsos. … Read more

The UK Covid inquiry has highlighted the preventable horror of a second Covid wave

The UK Covid inquiry has highlighted the preventable horror of a second Covid wave

Investigating Covid Latest reports One thing has become brutally clear: the first year of the epidemic – especially the second wave of Covid in the winter of 2020/21 – was devastating. And much of its destruction was preventable. Taken together, the evidence from NHS staff, affected families and the findings of the inquiry into the … Read more